Trending

Humira

AbbVie’s JAK inhibitor upadacitinib gets Priority Review

AbbVie’s JAK inhibitor upadacitinib gets Priority Review

AbbVie’s attempts to diversify beyond Humira have been boosted as its investigational drug upadacitinib has been granted Priority

X

AbbVie’s JAK inhibitor upadacitinib gets Priority Review

https://pharmaphorum.com/news/abbvies-jak-inhibitor-upadacitinib-gets-priority-review/

AbbVie wobbles as biosimilars bite Humira

AbbVie wobbles as biosimilars bite Humira

AbbVie’s shares slipped ahead of the weekend when its fourth-quarter revenues missed forecasts, after biosimilar competition – particularly

X

AbbVie wobbles as biosimilars bite Humira

https://pharmaphorum.com/news/abbvie-wobbles-as-biosimilars-bite-humira/

2018 in review: Humira biosimilars arrive in Europe

2018 in review: Humira biosimilars arrive in Europe

The emergence this year of Humira biosimilars in Europe followed a period of sustained momentum around the cheaper

X

2018 in review: Humira biosimilars arrive in Europe

https://pharmaphorum.com/views-analysis-sales-marketing/2018-review-humira-biosimilars-europe/

AbbVie, Pfizer reach licencing agreement for biosimilar Humira

AbbVie, Pfizer reach licencing agreement for biosimilar Humira

AbbVie has granted a non-exclusive patent license allowing Pfizer to sell its Humira (adalimumab) biosimilar in many countries

X

AbbVie, Pfizer reach licencing agreement for biosimilar Humira

https://pharmaphorum.com/news/abbvie-pfizer-reach-licencing-agreement-for-biosimilar-humira/

Has the NHS joined the biosimilars revolution?

Has the NHS joined the biosimilars revolution?

Biosimilars have cut the price of biologic drugs by up to 80% on the NHS, according to Paul

X

Has the NHS joined the biosimilars revolution?

https://pharmaphorum.com/oncology/nhs-joined-biosimilar-revolution/

FDA approves biosimilar of blockbuster Humira

FDA approves biosimilar of blockbuster Humira

A Humira biosimilar, produced by drug maker Sandoz, has been given the green light from the US Food

X

FDA approves biosimilar of blockbuster Humira

https://pharmaphorum.com/news/fda-approves-biosimilar-blockbuster-humira/

AbbVie braces for impact of Humira biosimilars in Europe

AbbVie braces for impact of Humira biosimilars in Europe

AbbVie looks set to lose several billion dollars in revenue from Humira, as its soon to expire European

X

AbbVie braces for impact of Humira biosimilars in Europe

https://pharmaphorum.com/news/abbvie-braces-for-impact-of-humira-biosimilars-in-europe/

Fourth Humira biosimilar set for EU approval

Fourth Humira biosimilar set for EU approval

European regulators have backed a new Humira biosimilar for approval, setting up a four-way race for the blockbuster’s

X

Fourth Humira biosimilar set for EU approval

https://pharmaphorum.com/news/humira-biosimilar-eu-sandoz-chmp/

Payday for AbbVie as Humira biosimilar delayed for five years

Payday for AbbVie as Humira biosimilar delayed for five years

Deal with Amgen signals exclusivity until 2023 for mega-blockbuster

X

Payday for AbbVie as Humira biosimilar delayed for five years

https://pharmaphorum.com/news/no-us-humira-biosimilar-likely-another-five-years/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com